Search
for
Sort by
Research 91–120 of 1000+
- FDA Reports of Alopecia as an Adverse Event to Isotretinoin
- Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Discrepancies in safety reporting for chronic back pain clinical trials: an observational study from ClinicalTrials.gov and publications
- Quantitative and qualitative analysis of individual experiences post botulinum toxin injection ‐ United Kingdom Survey
- Exosome-Based Therapies for Alopecia: A Systematic Review of Clinical Efficacy and Safety
- Cutaneous toxicities of new treatments for melanoma
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Comment on “Low dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series”: Adding further evidence about side effects
- Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment
- Finasteride toxicity information: “limited”, “poor quality”, “biased”
- Drug-induced hair colour changes
- Review of the Literature
- 054 Post Finasteride Syndrome: Guess Who-Demographics from FDA Database
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Pathogenetic Rationale for the Use of Exosomes Derived from Salmon Tissue in Patients with Androgenetic Alopecia: A Prospective Uncontrolled Observational Study
- Muscular Increase and Definition of the Back Contour Through Key Fat Grafting and Liposuction
- Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics
- Efficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic Alopecia: A Pilot Study
- Spironolactone for Female Acne: A Meta-analysis of Safety and Efficacy
- Clinical evaluation of the efficacy and safety of ‘ThriveCo anti-dandruff pre-shampoo treatment,’ containing ZenscalpinTM in the management of scalp dandruff in healthy adults
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health